Lv1
50 积分 2026-01-26 加入
666
Phase 1b/2 study of lisaftoclax (APG-2575) combined with azacitidine (AZA) in patients (pts) with treatment-naïve (TN) or prior venetoclax (VEN)-exposed myeloid malignancies
3个月前
已关闭
Safety and efficacy of lisaftoclax, a novel BCL-2 inhibitor, in combination with azacitidine in patients with treatment-naïve or relapsed or refractory acute myeloid leukemia
3个月前
已关闭
Lisaftoclax (APG-2575), a Novel BCL-2 Inhibitor, in Combination with Azacitidine in Treatment of Patients with Myelodysplastic Syndrome (MDS)
3个月前
已关闭
Venetoclax and decitabine vs intensive chemotherapy as induction for young patients with newly diagnosed AML
3个月前
已完结
皖公网安备34019202002308
